| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Unité de Biologie des Régulations Immunitaires, et
Unité de Programmation Moléculaire et Toxicologie Génétique (CNRS-URA1444), Institut Pasteur, Paris, France; and
Institute for Animal Science and Health (ID-DLO), Lelystad, The Netherlands
Competition for binding to MHC class II molecules between processed peptides derived from a single protein Ag is considered an important parameter leading to the presentation of a limited set of peptides by APCs. We tested the relevance of this competition process in a model Ag, the MalE protein, by deleting T cell epitopes or by introducing a competitor T cell peptide. We identified in DBA/1 (I-Aq) mice six immunodominant T cell determinants in the MalE sequence, 89–95, 116–123, 198–205, 211–219, 274–281, and 335–341. Synthetic peptides carrying these determinants were classified in three groups as weak, intermediate, or strong I-Aq binders in competition experiments with the PreS:T peptide of hepatitis B surface Ag. In vivo, synthetic MalE peptides with weak and intermediate MHC binding capacity were inhibited in their capacity to stimulate proliferative response in the presence of the PreS:T competitor peptide, whereas the strongest MHC binder was not. Strikingly, the insertion of the potent competitor PreS:T peptide into the MalE sequence, as a single copy or as four copies, did not inhibit the proliferative response to the six immunodominant peptides of the recipient protein. Moreover, deletion in the protein sequence disrupting either the weak (198–205) or strong (335–341) MHC binding determinant of MalE did not modify the proliferative response to the remaining T cell determinants as compared with wild-type MalE protein. Altogether, these results show that peptide competition for MHC binding may not represent the most important event in processes leading to immunodominance.
This article has been cited by other articles:
|
|
 |
|
  K. A. Richards, F. A. Chaves, and A. J. Sant Infection of HLA-DR1 Transgenic Mice with a Human Isolate of Influenza A Virus (H1N1) Primes a Diverse CD4 T-Cell Repertoire That Includes CD4 T Cells with Heterosubtypic Cross-Reactivity to Avian (H5N1) Influenza Virus J. Virol., July 1, 2009; 83(13): 6566 - 6577. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. R. Menges, S. A. Jenks, E. K. Bikoff, D. R. Friedmann, Z. A. G. Knowlden, and A. J. Sant An MHC Class II Restriction Bias in CD4 T Cell Responses toward I-A Is Altered to I-E in DM-Deficient Mice J. Immunol., February 1, 2008; 180(3): 1619 - 1633. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. P. Yeung, J. Chang, J. Miller, C. Barnett, M. Stickler, and F. A. Harding Elimination of an Immunodominant CD4+ T Cell Epitope in Human IFN-{beta} Does Not Result in an In Vivo Response Directed at the Subdominant Epitope J. Immunol., June 1, 2004; 172(11): 6658 - 6665. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Lopez, Y. Samino, U. H. Koszinowski, and M. Del Val HIV Envelope Protein Inhibits MHC Class I Presentation of a Cytomegalovirus Protective Epitope J. Immunol., October 15, 2001; 167(8): 4238 - 4244. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Podmore, J.L. Ebersole, and D.F. Kinane Immunodominant Antigens in Periodontal Disease: a Real or Illusive Concept? Critical Reviews in Oral Biology & Medicine, January 1, 2001; 12(2): 179 - 185. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Gugasyan, C. Velazquez, I. Vidavsky, B. M. Deck, K. van der Drift, M. L. Gross, and E. R. Unanue Independent Selection by I-Ak Molecules of Two Epitopes Found in Tandem in an Extended Polypeptide Antigen J. Immunol., September 15, 2000; 165(6): 3206 - 3213. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
